Pardes Biosciences

Pardes Biosciences

Biotechnology, 2173 Salk Ave Ste 250, Carlsbad, California, 92008, United States, 51-200 Employees

pardesbio.com

  • facebook
  • LinkedIn

phone no Phone Number: 14*********

Who is PARDES BIOSCIENCES

Pardes is a clinical-stage biopharmaceutical company created by and for this moment to help solve pandemic-sized problems, starting with COVID-19. We are applying modern reversible-covale...

Read More

map
  • 2173 Salk Ave Ste 250, Carlsbad, California, 92008, United States Headquarters: 2173 Salk Ave Ste 250, Carlsbad, California, 92008, United States
  • 2020 Date Founded: 2020
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from PARDES BIOSCIENCES

Pardes Biosciences Org Chart and Mapping

Employees

Katyna Borroto-Esoda

Executive Director, Clinical Virology

Ziping Yang

Vice President, Head of Translational Science

John Pottage

Non Executive Director

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Pardes Biosciences

Answer: Pardes Biosciences's headquarters are located at 2173 Salk Ave Ste 250, Carlsbad, California, 92008, United States

Answer: Pardes Biosciences's phone number is 14*********

Answer: Pardes Biosciences's official website is https://pardesbio.com

Answer: Pardes Biosciences's revenue is $1 Million to $5 Million

Answer: Pardes Biosciences's SIC: 2834

Answer: Pardes Biosciences's NAICS: 325412

Answer: Pardes Biosciences has 51-200 employees

Answer: Pardes Biosciences is in Biotechnology

Answer: Pardes Biosciences contact info: Phone number: 14********* Website: https://pardesbio.com

Answer: Pardes is a clinical-stage biopharmaceutical company created by and for this moment to help solve pandemic-sized problems, starting with COVID-19. We are applying modern reversible-covalent chemistry as a starting point to discover and develop novel oral drug candidates while reimagining the patient journey to access these medicines. By capitalizing on emerging patient-friendly innovations from telehealth to new at-home diagnostic tools, Pardes is cultivating and harvesting the fruits of systemic change. We are on a mission to stop a pandemic and start a movement so patients everywhere can get well sooner.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access